Keyphrases
Chicago
81%
Peritoneal Surface Malignancy
81%
Peritoneal Surface Disease
42%
Appropriate Management
39%
Medical Oncologist
39%
Palliative Care Physicians
39%
Pharmacist
39%
Surgical Oncologist
39%
Radiologists
39%
Enhanced Awareness
39%
Pathologist
39%
Breast
11%
Appendiceal Neoplasms
11%
Gastrointestinal Stromal Tumor
11%
Ovarian Neoplasms
11%
Colorectal Metastases
11%
Peritoneal Mesothelioma
11%
Desmoplastic Small Round Cell Tumor (DSRCT)
11%
Appendiceal Cancer
11%
Neuroendocrine Tumor
11%
Cytoreductive Surgery
9%
Gynecologic Oncologist
8%
Surgeons
6%
Overall Survival
6%
Pancreatectomy
6%
Umbilical Hernia Repair
5%
Pancreatic Cancer
5%
Endoscopic Eradication Therapy
5%
Papillary Adenocarcinoma
5%
Uncommon Presentation
5%
Postoperative Pancreatic Fistula
5%
Upfront Resection
5%
Medical Therapy
5%
State of the Field
5%
Chemotherapy Delivery
5%
Obesity Management
5%
Colorectal Cancer
5%
Intensive Care Unit Admission
5%
Splenectomy
5%
Immune Thrombocytopenic Purpura
5%
Risk Factors
5%
Autologous Vein
5%
Perioperative Complications
5%
Palliative Care
5%
Neoadjuvant Therapy
5%
Cadaveric
5%
Gastric Metastasis
5%
Appendicitis
5%
American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP)
5%
Single Institution
5%
Medicine and Dentistry
Cancer
100%
Oncologist
89%
Disease
49%
Symptomatic Treatment
45%
Pathologist
41%
Awareness
41%
Surgery
31%
Metastatic Carcinoma
19%
Appendix Tumor
17%
Pancreas Cancer
13%
Overall Survival
13%
Cytoreductive Surgery
13%
Pancreas Adenocarcinoma
13%
Pancreaticoduodenectomy
12%
Surgeon
12%
Ovarian Tumor
11%
Peritoneum Mesothelioma
11%
Desmoplastic Small Round Cell Tumor
11%
Gastrointestinal Stromal Tumor
11%
Neuroendocrine Tumor
11%
Distal Pancreatectomy
10%
Quality Improvement
9%
Surgical Technique
9%
Pancreas Fistula
9%
Pancreatectomy
8%
Neoadjuvant Therapy
8%
Surgical Infection
8%
Chemoradiotherapy
7%
Hyperthermic Intraperitoneal Chemotherapy
7%
Patient Referral
6%
Pancreas Islet Cell Tumor
6%
Combination Therapy
6%
Logistic Regression Analysis
6%
Glucagonoma
5%
Pheochromocytoma
5%
Cyclin-Dependent Kinase 9
5%
Low Drug Dose
5%
Surveillance, Epidemiology, and End Results
5%
Gemcitabine
5%
Preoperative Chemotherapy
5%
Postoperative Complication
5%
Lung Transplantation
5%
Medicare
5%
Splenectomy
5%
Intensive Care Unit
5%
Radiation Therapy
5%
Surgical Anastomosis
5%
Appendicitis
5%
Barrett Esophagus
5%
Chylous Ascites
5%
